封面
市場調查報告書
商品編碼
1991535

2026-2034年全球彈性體輸液幫浦市場規模、佔有率、趨勢與成長分析報告

Global Elastomeric Infusion Pumps Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計彈性體輸液幫浦市場將從 2025 年的 7.5547 億美元成長到 2034 年的 14.9018 億美元,2026 年至 2034 年的複合年成長率為 7.84%。

隨著醫療專業人員對高效便攜的給藥系統需求日益成長,全球彈性體輸液泵市場正穩步發展。彈性體輸液幫浦是一種無需電力即可以控制速率輸注藥物的一次性裝置。這些幫浦廣泛用於輸注抗生素、化療和疼痛管理藥物,尤其是在居家醫療環境中。

該市場的主要驅動力是居家醫療服務需求的不斷成長。患者和醫護人員擴大採用攜帶式輸液系統,以便在非醫院環境下進行治療。此外,癌症和感染疾病等慢性疾病的日益普遍也推動了對長期藥物輸注療法的需求。

隨著醫療保健系統致力於提升患者便利性和縮短住院時間,彈性體輸液幫浦市場前景廣闊。幫浦設計和藥物傳輸精度的技術進步有望提高患者安全性和治療效果。門診和居家醫療服務的日益普及也將進一步推動市場成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球彈性體輸液幫浦市場:依產品分類

  • 市場分析、洞察與預測
  • 恆速彈性體輸液泵
  • 可變流量彈性體輸液泵

第5章 全球彈性體輸液幫浦市場:依應用分類

  • 市場分析、洞察與預測
  • 疼痛管理
  • 化療
  • 抗生素和抗病毒治療
  • 其他

第6章:全球彈性體輸液幫浦市場:依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 其他

第7章 全球彈性體輸液幫浦市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Baxter
    • Fresenius Kabi AG
    • B. Braun SE
    • Ambu A/S
    • Leventon
    • SAU
    • NIPRO
    • Terumo Corporation
    • AVNS
    • Vygon Group
    • Smiths Group Plc
簡介目錄
Product Code: VMR11212096

The Elastomeric Infusion Pumps Market size is expected to reach USD 1490.18 Million in 2034 from USD 755.47 Million (2025) growing at a CAGR of 7.84% during 2026-2034.

The global elastomeric infusion pumps market is growing steadily as healthcare providers seek efficient and portable drug delivery systems. Elastomeric infusion pumps are disposable devices that deliver medications at a controlled rate without requiring electricity. These pumps are widely used for administering antibiotics, chemotherapy, and pain management treatments, particularly in home healthcare settings.

A major driver of this market is the increasing demand for home-based healthcare services. Patients and healthcare providers are increasingly adopting portable infusion systems that allow treatment outside hospital environments. Additionally, the rising prevalence of chronic diseases such as cancer and infections is increasing the demand for long-term drug infusion therapies.

The future of the elastomeric infusion pumps market appears promising as healthcare systems focus on improving patient convenience and reducing hospital stays. Technological improvements in pump design and drug delivery accuracy will likely enhance patient safety and treatment effectiveness. Growing adoption of outpatient and home healthcare services will further support market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Continuous Rate Elastomeric Infusion Pumps
  • Variable Rate Elastomeric Infusion Pumps

By Application

  • Pain Management
  • Chemotherapy
  • Antibiotic/Antiviral Therapy
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Baxter, Fresenius Kabi AG, B Braun SE, Ambu AS, Leventon, SAU, NIPRO, Terumo Corporation, AVNS, Vygon Group, Smiths Group plc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Continuous Rate Elastomeric Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Variable Rate Elastomeric Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Antibiotic/Antiviral Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ELASTOMERIC INFUSION PUMPS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Baxter
    • 9.2.2 Fresenius Kabi AG
    • 9.2.3 B. Braun SE
    • 9.2.4 Ambu A/S
    • 9.2.5 Leventon
    • 9.2.6 S.A.U
    • 9.2.7 NIPRO
    • 9.2.8 Terumo Corporation
    • 9.2.9 AVNS
    • 9.2.10 Vygon Group
    • 9.2.11 Smiths Group Plc